{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:09:21Z","timestamp":1794085761818,"version":"4.8.0"},"reference-count":33,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Urology"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Urinary tract infections (UTI) are common and costly, but standard urine culture (SUC) diagnostic tests have significant limitations. Emerging molecular techniques like multiplex polymerase chain reaction (PCR) offer rapid simultaneous detection of uropathogens and antimicrobial resistance (AMR) genes allowing timely targeted therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To compare the performance of Urine-ID\u2122 test, an expanded multiplex PCR panel designed to detect 26 uropathogens and 49 AMR markers against SUC for pathogen detection in individuals with suspected complicated UTI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and methods:<\/jats:title>\n                    <jats:p>\n                      A total of 56 urine specimens from individuals aged 50 and older, who exhibited UTI symptoms and failed previous therapy based on SUC results, were retrospectively analyzed using Urine-ID\n                      <jats:sup>\u2122<\/jats:sup>\n                      using the TaqMan\n                      <jats:sup>\u00ae<\/jats:sup>\n                      OpenArray plates on the QuantStudio 12K Flex Real-Time PCR System. Results of simultaneously collected PCR and SUC were compared at patient follow-ups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 56 suspected UTI cases, SUC failed to detect pathogens in 19.64% (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u200911\/56) of the specimens while PCR yielded negative results in 7.14% (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u20094\/56) of cases. SUC identified a specific organism in 50% (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u200928\/56) while PCR detected at least one uropathogen in 92.86% (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u200952\/56) of specimens. Data also revealed that a nonspecific result, \u201cMixed urogenital flora\u201d (MUG), was the most frequent outcome (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u200918\/45) obtained with SUC among positive samples. While SUC identified a single pathogen in 92.80% (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u200926\/28) of positive specimens, PCR detected additional co-infecting uropathogens in 71.20% (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u200937\/52) of positive samples. Of the 18 MUG and 11 negative samples using SUC, PCR identified treatable pathogens in 13 and 7 samples, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These results highlight the effectiveness of expanded real-time PCR panels for quickly and accurately identifying uropathogens, surpassing traditional SUC sensitivity. Adopting these advanced molecular techniques, particularly in suspected complicated UTI cases, improves diagnosis efficiency, leading to faster pathogen identification and treatment, ultimately reducing patient morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562872251342421","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:42:17Z","timestamp":1749534137000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Expanded PCR panel for uropathogen identification and treatment recommendations in urinary tract infections"],"prefix":"10.1177","volume":"17","author":[{"given":"Lindsey","family":"Leech","sequence":"first","affiliation":[{"name":"Vikor Scientific, Charleston, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bigley","sequence":"additional","affiliation":[{"name":"Vikor Scientific, Charleston, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Chew","sequence":"additional","affiliation":[{"name":"Vikor Scientific, Charleston, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Crawford","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of South Carolina, Charleston, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JeanAnn","family":"Vawter","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of South Carolina, Charleston, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9130-4979","authenticated-orcid":false,"given":"Manish P.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of South Carolina, 40 Pinnacle Parkway, Suite 212 Elgin SC 29045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir102"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw281"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-020-0362-4"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756287219832172"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab466.1608"},{"key":"e_1_3_4_7_2","unstructured":"American Urological Association. Medical student curriculum: adult UTI https:\/\/www.auanet.org\/meetings-and-education\/for-medical-students\/medical-students-curriculum\/adult-uti (2020 accessed 27 February 2025)."},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.20"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2019.10.018"},{"key":"e_1_3_4_10_2","article-title":"Real-world evidence that a novel diagnostic combining molecular testing with pooled antibiotic susceptibility testing is associated with reduced infection severity and lower cost compared with standard urine culture in patients with complicated or persistently recurrent urinary tract infections","volume":"1","author":"Ko DS-C","year":"2023","unstructured":"Ko DS-C, Lukacz ES, Juster IA, et al. Real-world evidence that a novel diagnostic combining molecular testing with pooled antibiotic susceptibility testing is associated with reduced infection severity and lower cost compared with standard urine culture in patients with complicated or persistently recurrent urinary tract infections. JU Open Plus 2023; 1: e00021.","journal-title":"JU Open Plus"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.12980\/APJTB.4.2014C423"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/microbiolres14020041"},{"key":"e_1_3_4_13_2","first-page":"257","article-title":"Comparison of polymerase chain reaction and urine culture in the evaluation of patients with complex urinary tract infections","volume":"13","author":"Kapoor DA","year":"2024","unstructured":"Kapoor DA, Holton MR, Hafron J, et al. Comparison of polymerase chain reaction and urine culture in the evaluation of patients with complex urinary tract infections. Biology (Basel) 2024; 13: 257.","journal-title":"Biology (Basel)"},{"key":"e_1_3_4_14_2","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies\u2014PubMed","volume":"351","author":"Bossuyt PM","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies\u2014PubMed. BMJ (Clin Res Ed) 2015; 351: h5527.","journal-title":"BMJ (Clin Res Ed)"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.660461"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2022.08.009"},{"key":"e_1_3_4_17_2","article-title":"MP77-15 Agreement of traditional urinary culture and multiplex PCR: results from a prospective study","volume":"203","author":"Vollstedt A","year":"2020","unstructured":"Vollstedt A, Oak R, Luke N, et al. MP77-15 Agreement of traditional urinary culture and multiplex PCR: results from a prospective study. J Urol 2020; 203: e1169.","journal-title":"J Urol"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit441"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001544"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2016.03.055"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2021.260"},{"key":"e_1_3_4_22_2","first-page":"141","article-title":"A diagnostic test combining molecular testing with phenotypic pooled antibiotic susceptibility improved the clinical outcomes of patients with non-E. coli or polymicrobial complicated urinary tract infections","volume":"15","author":"Korman HJ","year":"2023","unstructured":"Korman HJ, Baunoch D, Luke N, et al. A diagnostic test combining molecular testing with phenotypic pooled antibiotic susceptibility improved the clinical outcomes of patients with non-E. coli or polymicrobial complicated urinary tract infections. Res Rep Urol 2023; 15: 141\u2013147.","journal-title":"Res Rep Urol"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.020602-0"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2023.116015"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05179-0"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083637"},{"key":"e_1_3_4_27_2","volume-title":"Enterococci: from commensals to leading causes of drug resistant infection","author":"Kristich CJ","year":"2014","unstructured":"Kristich CJ, Rice LB, Arias CA. Enterococcal infection\u2014treatment and antibiotic resistance. In: Gilmore MS, Clewell DB, Ike Y, et al. (eds) Enterococci: from commensals to leading causes of drug resistant infection. Boston: Massachusetts Eye and Ear Infirmary, 2014."},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.3.6.613-625.1976"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.982429"},{"key":"e_1_3_4_30_2","article-title":"Candida urinary tract infections\u2014epidemiology, pathogenesis, diagnosis, and treatment: executive summary","volume":"52","author":"Fisher JF.","year":"2011","unstructured":"Fisher JF. Candida urinary tract infections\u2014epidemiology, pathogenesis, diagnosis, and treatment: executive summary. Clin Infect Dis 2011; 52(Suppl. 6): S429\u2013S432.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2019-0262"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S118892"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/ewjm.176.1.51"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017146"}],"container-title":["Therapeutic Advances in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562872251342421","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562872251342421","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562872251342421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:10:56Z","timestamp":1767647456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562872251342421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"alternative-id":["10.1177\/17562872251342421"],"URL":"https:\/\/doi.org\/10.1177\/17562872251342421","relation":{},"ISSN":["1756-2872","1756-2880"],"issn-type":[{"value":"1756-2872","type":"print"},{"value":"1756-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"article-number":"17562872251342421"}}